Vol. 2 No. 11 (2025)

Articles

• A 2025 meta-analysis in non–small-cell lung cancer (NSCLC) indicates glucocorticoid administration is significantly associated with worse progression-free survival (PFS) and overall survival (OS) for patients on ICIs

  A. Mohamed Sikkander, C. Hazarathaiah Yadav, Narendra Revanuri (Author)

  1-3

  • PDF

• Current Developments in Cyclophosphamide for Lymphoma: Immunomodulation, Metronomic Approaches, and Toxicity Control

  A. Mohamed Sikkander*, C. Hazarathaiah Yadav, Narendra Revanuri (Author)

  4-6

  • PDF

• AI Beneath: Innovations Driving Breakthroughs in Cardiology, Oncology, Hypertension, and Acute Care Medicine

  A. Mohamed Sikkander*, Joel J. P. C. Rodrigues, Hala S. Abuelmakarem, Manoharan Meena (Author)

  7-17

  • PDF

• Biomedical Engineering Innovations Driving Breakthroughs in Cardiology, Oncology, Hypertension, and Acute Care Medicine

  A. Mohamed Sikkander*, Joel J. P. C. Rodrigues, Hala S. Abuelmakarem, Manoharan Meena (Author)

  18-29

  • PDF

• Nanotechnology Beneath: Innovations Fuelling Advances in Acute Care Medicine, Cardiology, Oncology, and Hypertension

  A. Mohamed Sikkander*, Joel J. P. C. Rodrigues, Hala S. Abuelmakarem, Manoharan Meena (Author)

  30-38

  • PDF